Macro Briefing: 11 November 2020

Biden transition continues as Trump refuses to concede: WSJ
US reports record Covid-19 cases and hospitalizations on Tuesday: AP
US states offer no support for narrative that election was stolen: NYT
Upbeat vaccine news boosts expectations for global economic rebound: WSJ
Hong Kong’s pro-democracy lawmakers resign in protest: Reuters
Obamacare expected to withstand new challenge in Supreme Court: CNBC
Economic challenges are lurking for Biden presidency: Politico
China increasing puts fintech in the regulatory crosshairs: BBG
A leading candidate for Treasury Sec: Lael Brainard, a Fed governor: Fortune
Small business sentiment in US holds steady in Sep at pandemic high: NFIB
US job openings picked up in Sep but trend still slipping: Reuters

A New Burst Of Reflation Pricing In The Treasury Market

The bond market gave reflation a new run of consideration yesterday (Nov. 9) as Treasury yields shot higher. Was it a reaction to news over the weekend that Joe Biden won the Electoral College vote? Meanwhile, Pfizer’s announcement on Monday that an experimental COVID-19 vaccine is 90%-plus effective helped set reflationary hearts aflutter. It’s still too early to declare that a decades-long disinflationary trend has run out of road, but the possibility that regime shift has arrived, or is near, has traction… again.
Continue reading

Macro Briefing: 10 November 2020

Key Republicans decline to recognize Biden’s election win: NYT
Pfizer vaccine trial points to breakthrough for battling pandemic: Reuters
Europe runs low on ICU beds, hospital staff as virus spread rebounds: AP
Trump fires Defense Secretary Esper: CNN
China’s inflation falls despite economic rebound: Reuters
The US dollar could weaken under a Biden administration, analysts advise: CNBC
German investor confidence slides for a second month: BBG
Armenia and Azerbaijan announce end of fighting over Nagorno-Karabakh: AP
Can the head of GAO hold up a transition to a Biden administration? BBG
10-year Treasury yield rises to 0.96%, highest since March: CNBC

Macro Briefing: 9 November 2020

Biden presidency set to unwind Trump agenda with executive orders: FT
Trump advisers: Legal challenges to Biden victory is futile: BBG
Covid-19 will be a Biden administration’s first priority: NYT
Will pandemic overwhelm US health system before Biden takes office? Politco
Washington braces for uncertainty in Trump’s remaining time in office: TH
Democrats fear McConnel’s veto power in Senate: CNN
Goldman Sachs cuts economic growth outlook due to Covid-19’s resurgence: MW
US payrolls continued recovery in Oct but still far below per-pandemic level: BBG

Book Bits: 7 November 2020

The Mismeasure of Progress: Economic Growth and Its Critics
Stephen J. Macekura
Summary via publisher (Chicago U. Press)
Few ideas in the past century have had wider financial, political, and governmental impact than that of economic growth. The common belief that endless economic growth, as measured by Gross Domestic Product, is not only possible but actually essential for the flourishing of civilization remains a powerful policy goal and aspiration for many. In The Mismeasure of Progress, Stephen J. Macekura exposes a historical road not taken, illuminating the stories of the activists, intellectuals, and other leaders who long argued that GDP growth was not all it was cracked up to be.

Continue reading

Macro Briefing: 6 November 2020

Vote counting pushes Biden closer to winning the White House: Reuters
Federal judge blocks Trump campaign’s request to stop Philly vote count: Reuters
George vote counting gives Biden the lead in the state for the first time: BBG
Control of the Senate still unclear: depends Georgia runoff election in Jan: Politico
Tests of nasal spray that blocks coronavirus looks promising: NYT
Fed leaves rates near zero–warns of more coronavirus fallout for economy: CNN
October job cuts in US dropped to lowest number in seven months: CGC
US jobless claims fell again but remain unusually high: CNBC